MLC1 and endothelial dysfunction: In addition to the well-established thrombin-induced RhoA/MLC pathway, we defined a role for p38 MAPK signaling in thrombin-stimulated endothelial dysfunction that is independent of the RhoA/MLC pathway (4, 6).